These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Pratt RD; Perdomo CA Ann N Y Acad Sci; 2002 Nov; 977():513-22. PubMed ID: 12480794 [No Abstract] [Full Text] [Related]
24. Neuroleptic malignant-like syndrome due to donepezil and maprotiline. Ohkoshi N; Satoh D; Nishi M; Shoji S Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986 [No Abstract] [Full Text] [Related]
25. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549 [TBL] [Abstract][Full Text] [Related]
39. Advertisements for donepezil. More convincing evidence of efficacy needs to be cited. Greenhalgh T BMJ; 1997 Dec; 315(7122):1623; author reply 1624. PubMed ID: 9437303 [No Abstract] [Full Text] [Related]
40. [Post-marketing observational study of donepezil]. Ibach B Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]